Kalydeco May Increase Cataract Risk for Kids
The Food and Drug Administration (FDA) announced that a recent animal study suggests that children who use a cystic fibrosis pill made by Vertex Pharmaceuticals may be at risk for developing cataracts . The FDA has asked Vertex to update the drug’s label with that information and requested the company do a clinical study of children up to age 11 who take Kalydeco , according to Reuters